Assessment of the expression pattern of HER2 and its correlation with HER2-targeting antibody-drug conjugate therapy in urothelial cancer

Background: Human epidermal growth factor receptor 2 (HER2) overexpression is related to anti-HER2 therapy in many tumors. RC48- antibody-drug conjugate (ADC) has shown promising efficacy in patients with HER2-positive locally advanced or metastatic urothelial carcinoma (UC). The characteristic expr...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Huizi Lei, Yun Ling, Pei Yuan, Xieqiao Yan, Lin Wang, Yanxia Shi, Xin Yao, Hong Luo, Benkang Shi, Jiyan Liu, Zhisong He, Guohua Yu, Weiqing Han, Changlu Hu, Zhihong Chi, Chuanliang Cui, Lu Si, Jianmin Fang, Jun Guo, Xinan Sheng, Aiping Zhou, Jianming Ying
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Elsevier 2023-06-01
Edice:	Journal of the National Cancer Center
Témata:	Urothelial carcinoma Anti-HER2-ADC HER2 Fluorescence in situ hybridization Immunohistochemistry
On-line přístup:	http://www.sciencedirect.com/science/article/pii/S2667005423000182
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!